Home - Products - Others - Other Targets - Pelargonidin3-O-[6-O-(E)CaffeoylSophoroside]-5-glucoside

Pelargonidin3-O-[6-O-(E)CaffeoylSophoroside]-5-glucoside

CAS No. 361342-09-8

Pelargonidin3-O-[6-O-(E)CaffeoylSophoroside]-5-glucoside( ——— )

Catalog No. M39743 CAS No. 361342-09-8

Pelargonidin3-O-[6''-O-(E)CaffeoylSophoroside]-5-glucoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pelargonidin3-O-[6-O-(E)CaffeoylSophoroside]-5-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Pelargonidin3-O-[6''-O-(E)CaffeoylSophoroside]-5-glucoside
  • Description
    Pelargonidin3-O-[6''-O-(E)CaffeoylSophoroside]-5-glucoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    361342-09-8
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Retro-2 cycl

    Retro-2 cycl is an antiviral agent and a selective inhibitor of retrograde protein trafficking mediated by syntaxin-5 at the interface. Retro-2 cycl inhibits JCPyV(IC50s: 54 μM) and HPV16 pseudovirus(IC50s: 160 μM).

  • Cistanoside F

    Cistanoside F shows vasorelaxant, and antioxidative effects, it shows a strong free radical scavenging activity on 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and xanthine/xanthine oxidase (XOD) generated superoxide anion radical (O2-.).

  • 7-Methoxy-1-tetralon...

    7-Methoxy-1-tetralone may have insecticidal activity.